Chemo-Enzymatic Synthesis of Enantiopure β-Antagonist ( S )-Betaxolol
The β-blocker ( S )-betaxolol has been synthesized in 99% enantiomeric excess ( ee ) from the commercially available precursor 4-(2-hydroxyethyl)phenol. The racemic chlorohydrin 1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol was esterified with vinyl acetate catalyzed by lipase B fro...
Published in: | Catalysts |
---|---|
Main Authors: | , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
MDPI AG
2022
|
Subjects: | |
Online Access: | https://doi.org/10.3390/catal12121645 https://doaj.org/article/7c57bfdc357745489ee1dfb413380feb |
Summary: | The β-blocker ( S )-betaxolol has been synthesized in 99% enantiomeric excess ( ee ) from the commercially available precursor 4-(2-hydroxyethyl)phenol. The racemic chlorohydrin 1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol was esterified with vinyl acetate catalyzed by lipase B from Candida antarctica , which gave the R -chlorhydrin ( R )-1-chloro-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol in 99% ee with 38% yield. The enantiomeric excess of the R -chlorohydrin was retained in an amination reaction with isopropylamine in methanol to yield ( S )-betaxolol in 99% ee and with 9% overall yield. We are under way to improve the yield. |
---|